Quantification of MR: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 34: Line 34:
One particular echocardiographic technique used to measure the orifice area is measurement of the [[proximal isovelocity surface area]] (PISA).  The flaw of using PISA to determine the mitral valve regurgitant orifice area is that it measures the flow at one moment in time in the cardiac cycle, which may not reflect the average performance of the regurgitant jet.
One particular echocardiographic technique used to measure the orifice area is measurement of the [[proximal isovelocity surface area]] (PISA).  The flaw of using PISA to determine the mitral valve regurgitant orifice area is that it measures the flow at one moment in time in the cardiac cycle, which may not reflect the average performance of the regurgitant jet.


== Acknowledgements ==
==References==
The content on this page was first contributed by: C. Michael Gibson, M.S., M.D.
{{reflist|2}}
<!--
List of contributors:


== Suggested Reading and Key General References ==
[[Category:cardiology]]


== Suggested Links and Web Resources ==
{{WH}}
 
{{WS}}
== For Patients ==
-->
{{Circulatory system pathology}}
{{Congenital malformations and deformations of circulatory system}}
{{SIB}}
[[Category:Valvular heart disease]]
[[Category:Cardiology]]
[[Category:DiseaseState]]
 
{{Link FA|de}}
[[de:Mitralklappeninsuffizienz]]
[[es:Insuficiencia mitral]]
[[ja:僧帽弁閉鎖不全]]





Revision as of 04:10, 5 March 2011

WikiDoc Resources for Quantification of MR

Articles

Most recent articles on Quantification of MR

Most cited articles on Quantification of MR

Review articles on Quantification of MR

Articles on Quantification of MR in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Quantification of MR

Images of Quantification of MR

Photos of Quantification of MR

Podcasts & MP3s on Quantification of MR

Videos on Quantification of MR

Evidence Based Medicine

Cochrane Collaboration on Quantification of MR

Bandolier on Quantification of MR

TRIP on Quantification of MR

Clinical Trials

Ongoing Trials on Quantification of MR at Clinical Trials.gov

Trial results on Quantification of MR

Clinical Trials on Quantification of MR at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Quantification of MR

NICE Guidance on Quantification of MR

NHS PRODIGY Guidance

FDA on Quantification of MR

CDC on Quantification of MR

Books

Books on Quantification of MR

News

Quantification of MR in the news

Be alerted to news on Quantification of MR

News trends on Quantification of MR

Commentary

Blogs on Quantification of MR

Definitions

Definitions of Quantification of MR

Patient Resources / Community

Patient resources on Quantification of MR

Discussion groups on Quantification of MR

Patient Handouts on Quantification of MR

Directions to Hospitals Treating Quantification of MR

Risk calculators and risk factors for Quantification of MR

Healthcare Provider Resources

Symptoms of Quantification of MR

Causes & Risk Factors for Quantification of MR

Diagnostic studies for Quantification of MR

Treatment of Quantification of MR

Continuing Medical Education (CME)

CME Programs on Quantification of MR

International

Quantification of MR en Espanol

Quantification of MR en Francais

Business

Quantification of MR in the Marketplace

Patents on Quantification of MR

Experimental / Informatics

List of terms related to Quantification of MR

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Varun Kumar, M.B.B.S.; Lakshmi Gopalakrishnan, M.B.B.S.

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [3] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Determination of the degree of mitral regurgitation
Degree of mitral regurgitation Regurgitant fraction Regurgitant Orifice area
Mild mitral regurgitation< 20 percent
Moderate mitral regurgitation20 - 40 percent
Moderate to severe mitral regurgitation40 - 60 percent
Severe mitral regurgitation> 60 percent> 0.3 cm2

The degree of severity of mitral regurgitation can be quantified by the percentage of the left ventricular stroke volume that regurgitates into the left atrium (the regurgitant fraction).

Methods that have been used to assess the regurgitant fraction in mitral regurgitation include echocardiography, cardiac catheterization, fast CT scan, and cardiac MRI.

The echocardiographic technique to measure the regurgitant fraction is to determine the forward flow through the mitral valve (from the left atrium to the left ventricle) during ventricular diastole, and comparing it with the flow out of the left ventricle through the aortic valve in ventricular systole.

This method assumes that the aortic valve does not suffer from aortic insufficiency. The regurgitant fraction would be described as:


<math>\frac{forward\ flow\ through\ the\ mitral\ valve - flow\ through\ the\ aortic\ valve} {forward\ flow\ through\ the\ mitral\ valve}</math>

Another way to quantify the degree of mitral regurgitation is to determine the area of the regurgitant flow at the level of the valve. This is known as the regurgitant orifice area, and correlates with the size of the defect in the mitral valve.

One particular echocardiographic technique used to measure the orifice area is measurement of the proximal isovelocity surface area (PISA). The flaw of using PISA to determine the mitral valve regurgitant orifice area is that it measures the flow at one moment in time in the cardiac cycle, which may not reflect the average performance of the regurgitant jet.

References

Template:WH Template:WS



Template:WikiDoc Sources